USE OF BIODECODING IN PATIENTS WITH HYPERTENSION. ASSESSMENT AT 6 MONTHS

摘要

Introduction and Objective: High blood pressure is a worldwide health problem. The approach to the hypertensive patient should be an integral one. Biodecoding is one of the treatments that can be used. The aim of this study was to determine the efficacy of biodecoding in the treatment of patients with essential hypertension. Method: Experimental, controlled, randomized and longitudinal prospective study during 6 months in hypertensive patients, aged between 18 and 70 and of both sexes, attending the Cardiology Department of the Calixto García Hospital from September 2011 to February 2012 . The sample was divided into two groups: control (n=50) and biodecoding (n=58), without interruption of the treatment. Biodecoding was applied on three occasions and the patients were assessed at 15, 30, 90 and 180 days. Treatment was considered effective if 60% of patients maintained control of blood pressure for 6 months with absence of symptoms. Results: Blood pressure values significantly decreased in the biodecoding group compared to the control group (systolic blood pressure: 127 ± 13 vs. 119 ± 6 mmHg, p=0.001 and diastolic blood pressure: 82 ± 7 vs. 78 ± 7 mmHg. p=0.003), as well as hypertensive events and symptoms. Ninety-three percent of the biodecoding patients were controlled vs. seventy percent in the control group (p<0.003). The anti-hypertensive treatment was effective, but a higher percentage of patients were controlled and asymptomatic in the biodecoding group, 93% vs. 80 in the control group. Conclusions: Biodecoding was an effective method of blood pressure control.